Irsogladine Maleate

马来酸伊索拉定

Report date: 2023/11/02 13:56:59
NME

Base Information

Drug NameIrsogladine Maleate
Drug Alias Name依索拉定马来酸盐Dicloguamine MaleateGaslon NGaslon盖世龙 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsStomach UlcerPeptic Ulcer
Global Approved IndicationsStomach UlcerPeptic Ulcer
Approved Indications in ChinaStomach Ulcer
Original Approved Country/TerritoryJapan
Original Approved Date1988/01/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNippon Shinyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesQilu Pharmaceutical Co LtdNippon Shinyaku Co Ltd
Inactive CompaniesN/A
Active IndicationsStomach UlcerPeptic Ulcer
Inactive IndicationsN/A

Other Information

ATC CodeA02B
Related LinksWikipediaKEGG